News

The company’s multi-stage drug delivery technology is based on micron-sized particles of porous silicon particles which protect their payload from several key defenses used by the body and

CTP-499 is an analog of 1-((S)-5-hydroxyhexyl)-3,7-dimethylxanthine (HDX), an active metabolite of pentoxifylline and has a pleiotropic mechanism of action including angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor

Bend has provided Merck with the rights to have access to its proprietary spray-dried dispersion (SDD) technology, as per the agreement. Bend will also provide Merck with access

Proteoderm has used non-embryonic stem cells to develop a matrix of proteins (Matrix NC-138) used to harness the anti-aging potential in cosmeceutical products. Proteonomix president Michael Cohen said

The randomized trial was designed to assess whether the investigational alemtuzumab could achieve efficacy and safety improvements over the approved interferon beta-1a (Rebif). The trial enrolled patients who

The studies demonstrated once-monthly peginesatide, compared to epoetin alfa or epoetin beta dosed up to 13 times a month, maintained Hb levels in CKD patients on dialysis with

Iluvien is the company’s investigational sustained drug delivery system that releases sub-microgram levels of fluocinolone acetonide (FAc) to treat diabetic macular edema (DME) associated with diabetic retinopathy. FDA

During the study, Apixaban had failed to meet the primary efficacy outcome of superiority to Enoxaparin drug for the endpoint of VTE and VTE-related death. Brigham and Women’s

As per the agreement, ROP has received initial $100K licensing fee from BioStructures and will also receive an additional license fees as well as royalties on sales throughout